New asthma drug TR4 shows promise in early safety trial
Symptom relief
Completed
This early-stage study tested a new drug, TR4, in 12 adults with mild-to-moderate asthma. The goal was to check if the drug is safe and how it affects the airways. Participants received either TR4 or a placebo, and researchers measured lung function and other health markers.
Phase: PHASE1 • Sponsor: Trio Medicines Ltd. • Aim: Symptom relief
Last updated May 26, 2026 12:00 UTC